Review Pembrolizumab (Keytruda): CADTH Reimbursement Recommendation: Indicator: Together with chemotherapy, for that procedure of Grownup sufferers with regionally recurrent unresectable or metastatic triple-destructive breast cancer that have not received prior chemotherapy for metastatic illness and whose tumours Specific programmed mobile Demise-ligand one (blended beneficial ratin... https://charless023gtg6.wikicorrespondent.com/user